Shivom is pleased to announce its plans to buyback up to 30 million OMX tokens or approximately 5% of current circulating supply in preparation for Shivom’s beta platform release plans in 2019. Beyond simply removing some OMX from current market conditions, Shivom plans to allocate the repurchased OMX tokens exclusively for incentivizing early adopters and driving community engagement on the Shivom platform.
According to Shivom CEO Henry Ines, “the buyback program is part of a multi-prong strategy to accelerate growth of the Shivom ecosystem, onboard new users, drive community awareness and engagement and ultimately to further enhance the value of the Shivom platform and the OMX token ecosystem.”
The repurchased tokens will be utilized to provide incentives and benefits particularly to new users, who upload their existing genomic data file on to Shivom’s secure platform and for those who purchase Shivom-branded kits and services in 2019. The buyback program will commence on 01 November 2018 and is expected to conclude by 31 January 2019.
In the interim period, Shivom also plans to release its ‘alpha’ platform on a limited basis for early testing and feedback purposes. The company in parallel also continues to advance its clinical R&D and pilot projects.
Blockchain can help you control, protect and share your health data — helping you and others live healthier, longer lives
Exciting advances in precision medicine over the past decade should mean you and your family are now receiving advanced levels of healthcare and disease prevention based on your genetic makeup.
Researchers and health professionals across the world should be enjoying access to a vast resource of genomic sequencing data and health records — helping them discover cures and treatments for every type of disease.
However, the reality is far different.
An ocean of data about your health and the health of others is likely to be spread across many databases. You probably have little ability to view or update this data, let alone control who has access to it.
As for genomic data, only a small percentage of people have had theirs sequenced — largely because there isn’t a secure place to hold and leverage it.
Time to take control
This is a tragedy. You should have the opportunity to own your health and DNA data, and to maintain total control over it. You should have up-to-date information about the diseases you are predisposed to. Every few months, your data dashboard should be updated to inform you of the latest insights scientists have about your DNA.
If you know you’re genetically predisposed to osteoporosis, you should be able to proactively take steps to avoid its onset. If you’re aware there is a high chance of being afflicted by a certain type of cancer, you should be regularly tested to ensure you can catch it early.
Health apps and silos
There are many ongoing initiatives across the globe aiming to facilitate the storage and sharing of genomic data, and thereby enable the progress of precision medicine. Health apps based on genomic and other health data are good examples. But they tend to be competing against each other and creating even more data silos.
Meanwhile, a few large businesses hold the monopoly on most genomic data, and make large profits from selling it to third parties, usually without sharing the earnings with the data donor.
This stifles research and innovation and prevents medicine and healthcare moving forward at the pace it should.
You and your doctors are being denied vital knowledge about your health, and brilliant scientists are being denied access to genomic datasets that could help them gather potentially transformational information that could lead to the eradication of diseases.
Not only is your future health being compromised by the current system, but your health data is being left vulnerable too. In the wake of major data breaches like those at Yahoo! and Equifax, it’s hard to trust any organisation with sensitive data stored on cloud databases or local servers.
The release on the internet of your data records could have huge implications on your personal relationships, your future employment, your health insurance and your general wellbeing. Cyber criminals know this, so medical data will increasingly be targeted to leverage money from health organisations and patients themselves.
It’s no wonder few people are largely unwilling to map out their DNA and risk this data being spread across the internet.
A blockchain solution
But blockchain-based technology could be the solution everyone is waiting for.
Its distributed ledger technology removes the vulnerabilities associated with cloud databases. This means it would be safe to store even the most sensitive DNA and healthcare data on the blockchain, without fear of it being stolen or misused in a cyber attack.
A centralized health data hub built on the blockchain could let you maintain full ownership of this data, allowing you to share it with health professionals.
Let’s imagine you’re visiting a specialist doctor for a consultation and tests. She would just need a laptop or mobile device to access your health data in the ecosystem — using a private key (in other words a temporary password) supplied by you. At no time would the data be stored in her own computer or cloud database. And she would only have access to your data while you were under her care.
If you wanted to share the data with a research firm, you could give them access to your data in anonymised form for a certain period, and perhaps receive a payment in exchange.
A new ecosystem
Healthcare and wellness providers such as clinics, pharmaceuticals, research organizations, governments, patient-support groups and insurance companies could join an ecosystem built around this blockchain technology.
They would no longer have to compete with each other to gather data. It would be there for them all to use — for example, to boost clinical trials or facilitate drug research and development. This data could be easily sharable and interoperable across technological, geographic, jurisdictional, and professional boundaries.
Such a system could offer patients access to applications that leverage their data and enhance their wellbeing and health — for example, nutritional and fitness advice, treatment plans, genealogy, disease predisposition, and lifestyle management.
Looking into the future, as more personalized biological information becomes available, services could be offered that are based not only on genomic data, but also other health, biological, and environmental information, facilitating new insights into disease processes.
This is an exciting time in healthcare. Soon, you’ll have the power to leverage your DNA and health data to live a longer, healthier life, while helping billions of others on the planet.
All the technologies are in place. The world just needs a suitable health data platform.
About the Author
Dr Axel Schumacher who has over 20 years’ experience in the field of genetics; and is the Chief Scientific Officer of blockchain-enabled genomic data-hub startup Shivom. Shivom’s platform aims to be the largest genomic & healthcare data-hub on the planet, allowing the world’s population to have their genome sequenced and securely stored with the help of blockchain technology.
We are thrilled to have received such creative t-shirt design ideas. After browsing through all the submissions, we have decided to award Senthil as the winner of last month’s community t-shirt contest. Besides complying to the specification given, his design was creative and tied into our core product offering.
As promised, Senthil will receive 5,000 OMIX tokens. Thanks to everyone who participated and made this contest a stupendous success. Stay tuned to know more about our next contest.
Here at OMIX Ventures Pvt Ltd. Project SHIVOM (Token Ticker: OMX), now post-ICO and focused on execution and growth, the leadership team has decided to make some significant management changes to ensure efficient execution and platform roll out.
We’re thrilled to announce that Henry Ines has been named as Chief Executive Officer of the global blockchain-based genomics and precision medicine services company.
Henry has deep experience and knowledge of strategic development, corporate finance, startup scaling and execution based on decades of professional experience to include years as a VC, while working in Silicon Valley and Asia as a partner at Draper Dragon Fund, DFJ Dragon Fund and DragonVenture and focusing on early stage investments in frontier technologies to include FinTech & blockchain, artificial intelligence and VR/AR. Henry continues to serve on the advisory board of multiple Blockchain and Silicon Valley tech startups and serves as a mentor to leading incubators and accelerators. Henry is also a lecturer at the Nanyang Technopreneurship Center (NTC), Nanyang Technological University (NTU) and is a Senior Member of the World Education Blockchain Association (WEBA) in Singapore. He began his career at McNeil Consumer Products Company, a subsidiary of Johnson & Johnson, and as a management consultant to Fortune 100 companies while working at Price Waterhouse LLP. Henry holds a BS in Finance from Pennsylvania State University in University Park, PA and an MBA from Duke University Fuqua School of Business in Durham, NC.
“As we enter the Post-ICO phase, I am thrilled to lead the team at SHIVOM, focusing on tackling the many problems associated with the global healthcare system through genomics. The current healthcare system continues to be inefficient and face considerable challenges. Patients’ data continues to not be secure as is evident with the recent disclosures of data breaches. Additionally, many of the prevailing genetics companies and healthcare intermediaries continue to advance business models and practices that are not necessarily consistent with and in the best interests of donors or patients. We are looking forward to being able to empower individuals by providing significant insights into their genomes and health, tools for better managing and determining who has access to personal healthcare data, and enabling individuals to better manage their health and wellness through SHIVOM’s secure blockchain-based technology platform and healthcare ecosystem.”
Dr. Axel Schumacher, company co-founder who has been CEO up to now will continue as Chief Scientific Officer, leveraging his extensive research background and expertise in genomics and precision medicine. Additionally, Dr. Natalie Pankova moves into the role of Chief Operating Officer, and will lead operations out of our London office, leveraging her background in startup operations, business development and R&D, as well as her deep involvement in the global healthcare blockchain community. We believe these roles reflect the most direct path to success for our company, our supporters, and our vision.
SHIVOM cannot wait to build the world’s largest genomics datahub to help support clinical trials, advance research and development and drug discovery process globally, and ultimately work to democratize genomics for all. It is our mission to not only maintain a secure and safe platform for our users and web-market players, but also address the genomic-based complex and rare diseases such as diabetes utilizing advanced technologies such as blockchain and artificial intelligence.
We have a very special team that is dedicated to SHIVOM’s mission and working hard to execute in accordance with the company’s roadmap and growth strategy. As a startup, we must be nimble, iterate as needed and quickly respond to dynamic and evolving conditions. We are confident about our new changes, and keen to work together in new capacities to more effectively execute on our vision and take the company to new heights.
Thank you for your continued support as we enter this new wave of development, and stay tuned into our media outlets for more exciting news coming soon!
Congratulations on joining and contributing to the Shivom’s presale!
Now is when the fun begins. We are offering every Shivom user a chance to earn more bonuses through referrals. Our referral program is simple and has the potential for high returns. All you have to do is share the unique referral link you receive in your email after you have created an account on the Shivom dashboard.
If you still haven’t registered for the OmiX presale you can visit the Tokensale dashboard — https://tokensale.shivom.io/ and complete the registration process.
Referral program is based on your network!
When you receive your referral link, you can send this link to your friends and family and receive 5% bonus every time those you referred purchase OmiX tokens from their account.
The referrals program is not limited to a one-time reward. This is a 3-tier referral code that plays on network effects, which means you will get a 5% bonus for every new user and they also receive a bonus amounting to 5%. They can also share the unique referral link they receive with their friends, which in turn gives them 5% bonus, and gives you 4%. Subsequent sharing of the referral link by those friends will allow you to still enjoy a 3% bonus on their purchased tokens.
Overall, for three subsequent sharings of referral links in your network will allow you to receive a bonus of 5%, 4%, and 3% from your connections.
For any queries regarding Shivom’s referral program, please contact us at:
990 Million OmiX tokens for sale at 1 ETH = 7000 OmiX
First 15 000 ETH worth of tokens will be sold at 10% discount on 16th April Bonus will decrease by 1% each day
Hard cap: 75,000 ETH
Soft Cap : 20,000 ETH ( Already achieved)
Minimum transaction limit: 0.00014286 ETH
Min individual cap: 1 ETH
Caps will be reviewed after 24 hours, if tokens remain
How to begin?
Create an account — Register on the Shivom website and create an account at: https://tokensale.shivom.io/. Verify your email address by clicking on the email confirmation you receive.
Complete KYC — You will only be able to get your OmiX tokens after a verified KYC. You will still be able to purchase OmiX before your KYC has been verified, however your OmiX tokens will only appear in your wallet AFTER you have passed verification. After you have created your account, you need to further provide your proof of ID with a photograph and additional information. It may take up to 24 hours for your KYC to be completed and your identity to be verified. Please check your spam folder in case you don’t receive the KYC confirmation email in your inbox. If you receive an email within 24 hours which says that your identity has not been verified, please re-submit the KYC application by following the instructions in your email.
We are accepting ETH, BTC, DASH, LISK, LTC, QTUM, NEM, MONERO, RIPPLE, VERGE, ZCASH, NEO
Wait for the launch time (April 16th 1pm GMT). Once you’ve registered and submitted KYC, you can log in to your account on https://tokensale.shivom.io at the sale start time and you will be ready to buy OmiX. To buy OMX in the token sale using our platform, please follow step by step guide at this link
We noticed that many of you have already joined our whitelist and have signed up for the presale event scheduled to go live on April 16th, 2018 at 1 PM GMT. To continue with your journey as part of our community we recommend that you register on our Tokensale Dashboard as soon as possible to ensure that your purchase of OmiX tokens goes smoothly.
Here you will be able to complete your KYC, which is a mandatory step before purchasing tokens, and subsequently, the token purchase will be available to you once the sale goes live.
The future of genomic data is here and it’s Shivom!
Shivom, the blockchain project with the goal of becoming the world’s largest genomic data hub, has gained notable momentum in the blockchain and cryptocurrency space and continues to do so as it’s public token sale draws close. To date Shivom has captured the attention of cryptocurrency leaders, government administrations including those in India and Europe, artificial intelligence scientists, and experts in digital data security. Shivom with its unique use of blockchain technology is well on its way to revolutionize the storage and analysis of DNA data and empoy it for guiding and improving precision medicine and biotechnology R&D.
Shivom is headed by a team of geneticists, scientists, digital currency experts, and proficient business developers. The project is one of the most anticipated blockchain projects of the near future, and with the ability for users to control their genomic data using advanced encryptions, provision of incentives to volunteers who donate data for medical research, and the ability to use services and apps in a decentralized marketplace, it is set to revolutionize not just the course of genomics but also global healthcare as a whole.
Shivom has recently announced a number of exciting partnerships, including those with the government in Andhra Pradesh to sequence up to 60 million people in that province of India, starting with a pilot study after the close of the token sale, as well as with publicly traded company Genetic Technologies Limited for development of predictive genetic tests and use of accredited laboratories. A number of influential officials such as Former Prime Minister of Estonia, Taavi Rõivas and European member of parliament, Antanas Guoga and top notch scientists have joined the Shivom Innovation Council to help guide the company’s growth and development efforts, and we are in line for more exciting partnerships and developments in the coming weeks!
Throwing light on various aspects of Shivom as a DNA data-hub, a potential global health game-changer, and major new cryptocurrency project, the article presents a holistic view of Shivom’s capability and its prospects in the ICO market and as a driver of healthcare as it strategically integrates blockchain technology with DNA Data.
The article is a must-read for anyone who wants to be further informed about Shivom, the panel of experts on board, insights about the OmiX token, partnerships, use of blockchain and its position among the noteworthy blockchain projects.
An excerpt from the article states, “Shivom ecosystem will function in a decentralized way by using blockchain technologies, integrating the best protocols for advanced encryption and the combination of this with Artificial Intelligence.”
Our crowdsale is only a few days away and in order to ensure the safety of your OmiX token purchase, we are sharing a few tips you can follow to fully secure your participation in the public presale, launching on April 16th, 1PM, GMT.
As a member of the Shivom community, please note that each step mentioned below is essential to ensure the safety and security of your purchase of OmiX tokens.
Tips to safeguard your contribution to the Shivom Crowdsale!
Ignore Spam Messages — Shivom will never send an ambiguous or enticing message concerning your purchase or our initial offerings. Please note we will neither share or ask for information such as the contribution address, or make an incredible offer through a private message. All our messages will be sent through our verified Telegram group which can be visited at: https://t.me/projshivom You should be aware of scammers who impersonate and imitate website design, content, and information of founders in order to obtain sensitive data from the community. Do not respond to messages you may suspect of being unverified or without Shivom’s recognizable and official signia.
Admin and Official Messages — All relevant messages will be sent through official interfaces such as the website, Telegram, social media or the official newsletter. Kindly do not respond to messages which are dubious in their official status.
Bookmark/ Email the Official Website URL — Many times, scammers can create an identical website of the parent brand which can fool people and also obtain vital information from them. Kindly bookmark the official website of Shivom (https://shivom.io/) and other official online domains related to Shivom, such as social media, telegram group, etc.
Save Official Email Addresses — In order to steer clear of fake or spam emails, save the Shivom email addresses in your primary email so that the emails show up in your inbox and not in the spam folder. This will ensure that the Shivom email is not counted as spam by your email client and you can easily identify a scam email in case you receive one as it will automatically be sent to your spam folder. Even when you have received the email in your inbox, always double check the information of the sender before replying.
Do Not Share Your Shivom Account or Related Information with Anyone — Keep your contributions to our project as private as possible and do not share it with individuals you cannot trust with sensitive information. Shivom officials themselves will never ask or coax you to share unnecessary or unrequired information. PLEASE ONLY SEND ETH TO YOUR UNIQUE PARTICIPATION ADDRESS.
Please do not disclose crucial information about your Shivom account to anyone. We have also implemented some rules for the token sale so that safety and security of your data can remain intractable. These rules will be applied 30 minutes prior to the Token Sale and be in place up until 24 hours after the end of the Token Sale.
Complete your KYC and obtain your encrypted key.
30 minutes before the token sale begins, the group will be muted and only Shivom admins will be able to write on the group.
There’s a functionality in place where the bot will prevent accepting more than two messages from the same user and will delete two consecutive messages from the same user. If the user persists then the bot can ban them.
Our system also bans anyone posting any ETH address or link immediately.